Clinic of Rheumatology, Nephrology and Occupational Pathology named after E.M. Tareeva

History

2024: Initiation of treatment with unique genetic engineering technology

On October 16, 2024, at the E. M. Tareev Clinic of Rheumatology, Nephrology and Occupational Pathology of Sechenov University, the use of unique domestic genetic engineering technology for the treatment of rheumatoid arthritis began. The new method is based on the use of monoclonal antibodies developed by Russian pharmaceutical companies.

According to Sechenov University, olokizumab and levilimab, created by R-Pharm and Biocad, are used for treatment, respectively. These drugs block cytokines that cause autoimmune and inflammatory processes in rheumatoid arthritis.

𝓲

Freepik

Director of the Clinic of Rheumatology, Nephrology and Occupational Pathology, Corresponding Member of the Russian Academy of Sciences, Professor Sergei Moiseev noted that Russian drugs open up additional opportunities in the treatment of rheumatoid arthritis. According to him, patients can receive relief after the first injection.

It is important to note that treatment and hospitalization in the clinic are carried out under the compulsory health insurance (compulsory medical insurance) policy. This makes innovative therapy available to a wide range of patients from different regions of Russia. Currently, more than 60% of hospital patients in the clinic are residents of other cities of the country.

Rheumatoid arthritis is one of the most common joint diseases of inflammatory origin. According to statistics, about 1-1.5% of the world's population suffers from it. The disease often develops at a young age and can lead to a decrease in quality of life, disability and disability.

The drugs used in the clinic have previously shown their effectiveness in the treatment of COVID-19. Olokizumab became the first original domestic biotechnological drug included in the recommendations of the Ministry of Health of Russia on the prevention, diagnosis and treatment of coronavirus infection.^[1]

Notes